During the past decade, Stormont-Vail Regional Health Center conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 10 clinical trials were completed, i.e. on average, 250% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Stormont-Vail Regional Health Center" #1 sponsor was "National Cancer Institute (NCI)" with 8 trials, followed by "SWOG Cancer Research Network" with 3 trials sponsored, "Alliance for Clinical Trials in Oncology" with 2 trials sponsored, "Pfizer" with 2 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 2 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Stormont-Vail Regional Health Center" #1 collaborator was "National Cancer Institute (NCI)" with 8 trials as a collaborator, "Eastern Cooperative Oncology Group" with 4 trials as a collaborator, "NCIC Clinical Trials Group" with 3 trials as a collaborator, "Cancer and Leukemia Group B" with 2 trials as a collaborator and "SWOG Cancer Research Network" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Stormont-Vail Regional Health Center" are "Breast Cancer" (2 trials), "ADH Inappropriate" (1 trials), "Adenocarcinoma of the Colon" (1 trials), "Adenocarcinoma of the Rectum" (1 trials) and "Advanced Breast Cancer" (1 trials). Many other conditions were trialed in "Stormont-Vail Regional Health Center" in a lesser frequency.

Most popular intervention types in "Stormont-Vail Regional Health Center" are "Drug" (16 trials), "Other" (10 trials), "Biological" (6 trials), "Diagnostic Test" (1 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Paclitaxel" (4 trials), "placebo" (4 trials), "Bevacizumab" (3 trials), "Carboplatin" (3 trials) and "Laboratory Biomarker Analysis" (3 trials). Other intervention names were less common.

The vast majority of trials in "Stormont-Vail Regional Health Center" are 18 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Stormont-Vail Regional Health Center". undefined are not yet recruiting, 1 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Stormont-Vail Regional Health Center, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Stormont-Vail Regional Health Center, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".

Stormont-Vail Regional Health Center has several departments that took part in Clinical trials: "Cotton O'Neil Cancer Center / Stormont Vail Health" - 159 trials, "Cotton-O'Neil Clinical Research Center, Hematology and Oncology" - 3 trials